Frontlight ResearchEarly access
Trial site
Grenoble
- 8running trials
- 7closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia5 trials
- Coronary artery disease2 trials
- Metastatic breast cancer2 trials
- Myelodysplastic syndromes2 trials
- Stroke2 trials
- Familial hypercholesterolaemia1 trial
- High blood pressure1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Multiple sclerosis1 trial
- Myeloproliferative neoplasms1 trial
- Pulmonary arterial hypertension1 trial
- Phase
- Phase 37 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Active, not recruiting6 trials
- Completed5 trials
- Recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals15 trials
Running trials
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- Multiple sclerosis1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Terminated
Completed
Terminated
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 17 Nov 2026